Trial Profile
A phase I study for the safety, tolerability, pharmacokinetics and phamacodynamics of multiple oral 100,200 and 400mg doses of yogliptin tablets in healthy Chinese volunteers
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 23 Oct 2018
Price :
$35
*
At a glance
- Drugs Yogliptin (Primary)
- Indications Diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Easton Biopharmaceuticals
- 23 Oct 2018 New trial record